Pharmacists to Benefit Equally from Drug Price Hikes
Ministry of Health Updates Pricing Regulations for Pharmaceutical Products
The Ministry of Health recently announced an update to the pricing regulations for human medical products in Turkey. The announcement, published in the Official Gazette, stated that the pricing would now be based on the periodic euro exchange rate changes.
According to the new regulations, the pricing of pharmaceutical products will be determined by a certain percentage of the average euro value of the previous year. This update was made to ensure budget discipline and to align with international practices where the pricing of both domestically manufactured and imported drugs is regulated.
One of the main reasons for this update is to prevent income losses for pharmacists. With the previous regulations, pharmacists often faced challenges as drug prices remained constant while costs increased. This led to many drugs being sold at a loss, impacting the profitability of pharmacies.
Under the new regulations, pharmacists’ profitability goals will be adjusted during each exchange rate update. This means that pharmacists will be able to maintain their profitability and avoid income losses as drug prices fluctuate.
Overall, the update to the pricing regulations for pharmaceutical products aims to bring more stability and fairness to the industry, ensuring that pharmacists can continue to provide essential medical products to the public.
